Kelly D Moynihan

US Patent:

53123379, May 17, 1994

Filed:

Jun 8, 1992

Appl. No.:

7/894823

Inventors:

J. Christopher Flaherty - Topsfield MA
William J. Gorman - S. Hamilton MA
Paul V. Fenton - Marblehead MA
Kelly A. Moynihan - Marblehead MA
Andrew M. Mailloux - Lawrence MA
Thomas M. Young - Traverse City MI

Assignee:

Strato Medical Corporation - Beverly MA

International Classification:

A61M 1100
A61M 532
A61M 2500
F16L 2700

US Classification:

604 93

Abstract:

A connector for detachably securing an end of a tube, such as a catheter, to a fluid port of a fluid transfer device, such as an implantable device, the connector having a body part which defines a coupler for coupling to a coupler receiver of the transfer device. The connector includes a sleeve which fits within the body part and defines an aperture for compressively receiving an end of the tube which has been fitted over a fluid port of the transfer device. The body part is rotatable about the sleeve to facilitate coupling of the coupler and coupler receiver. In one embodiment the sleeve has an inner diameter at one end large enough to slide freely over the tube when it is fitted over the fluid port, and the diameter decreases at an intermediate point along the length of the sleeve to provide for compressive axial movement of the tube to form an annular thickness portion of the tube where it abuts the face of the transfer device.

US Patent:

20190054145, Feb 21, 2019

Filed:

Feb 10, 2017

Appl. No.:

16/076597

Inventors:

- Cambridge MA, US
- Stanford CA, US
Cary Francis OPEL - Somerville MA, US
Kelly Dare MOYNIHAN - Allston MA, US
Jennifer R. COCHRAN - Stanford CA, US
Byron Hua KWAN - Seattle WA, US

International Classification:

A61K 38/20
A61K 39/395
A61K 39/00
A61K 47/60
A61K 47/68
A61K 47/64
A61P 35/00

Abstract:

The present invention provides a method of treating cancer with a combination of IL-2 (e.g., extended-PK IL-2), an integrin-binding-Fc fusion protein, and a cancer vaccine. The methods of the invention can be used to treat a broad range of cancer types.

US Patent:

20170224777, Aug 10, 2017

Filed:

Aug 12, 2015

Appl. No.:

15/501535

Inventors:

- Cambridge MA, US
Darrell IRVINE - Arlington MA, US
Cary Francis OPEL - Somerville MA, US
Kelly Dare MOYNIHAN - Allston MA, US

International Classification:

A61K 38/20
C07K 16/40
A61K 45/06
A61K 39/385
A61K 39/39
A61K 39/395
A61K 38/38
A61K 39/00

Abstract:

The present invention provides a method of treating cancer with a combination of IL-2 (e.g., extended-PK IL-2), a therapeutic antibody or fragment thereof, and a cancer vaccine. The methods of the invention can be used to treat a broad range of cancer types.

US Patent:

20170216403, Aug 3, 2017

Filed:

Aug 12, 2015

Appl. No.:

15/501246

Inventors:

- Cambridge MA, US
Darrell IRVINE - Arlington MA, US
Cary Francis OPEL - Somerville MA, US
Kelly Dare MOYNIHAN - Allston MA, US

International Classification:

A61K 38/20
C07K 16/28
C07K 16/30
A61K 39/395
A61K 39/00

Abstract:

The present invention provides a method of treating cancer with a combination of IL-2 (e.g., extended-PK IL-2), a therapeutic antibody or fragment thereof, and an immune checkpoint blocker. The methods of the invention can be used to treat a broad range of cancer types.